The purpose of this course is to familiarize providers with a comparative review of two drugs, Siponimod and Sotagliflozin. Siponimod is a drug that could potentially improve the quality of life of patients suffering from Multiple Sclerosis. Sotagliflozin is a medication that could potentially be used in combination with regular insulin therapy to reduce patient blood sugar levels and help keep them low for a longer period of time.
This continuing nursing education activity was approved by the Colorado Nurses Association, an
accredited approver by the American Nurses Credentialing Center’s Commission on